View Full Version : General Cancer News
- Viewpoints: Sebelius on medical mistakes; Stockman on solving deficit; Fox on Medicar
- Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45
- FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment
- NIH awards RXi with SBIR grants to develop novel RNAi therapeutics
- Nationwide researchers to launch Oncotype DX test phase III trial in breast cancer
- CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC
- Maternal consumption of omega-3 fatty acids during pregnancy reduces risk of childhoo
- New nanoparticle imaging agent can help diagnose heart disease, breast cancer
- Enrollment complete in Unigene's oral PTH Phase 2 osteoporosis study in postmenopausa
- FOIA request on Avastin filed with the FDA
- Celgene non-GAAP total revenue increases 40% to $1.11 billion
- FDA accepts OncoMed's IND filing for OMP-18R5 in Phase 1 clinical trial for advanced
- New PET imaging clinical trial to improve early esophageal, lung cancer detection
- New innovative pilot project to combat surgical infections
- MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals
- Researchers discover possible role of SCCA in breast cancer progression
- UMMS, RXi receive MLSC grant to develop RNAi therapeutics for ALS
- Reimbursement policy influences choice of IMRT for treating breast cancer
- Annual mammogram sufficient follow-up after BCT for breast cancer patients
- FDA approves Abbott's AndroGel for hypogonadism treatment in men
- IMPAKT 2011 conference to highlight new breast cancer studies
- Mammography screening can benefit women under age 50
- MarginProbe System meets its primary endpoints: Dune Medical Devices
- Alcohol and raised cancer risk: Report
- USPSTF recommendations negatively impact yearly mammograms among 40-49 year old women
- Watson launches Generess Fe low-dose oral contraceptives in the U.S.
- Statins can play crucial role to reduce lung damage in severe abdominal sepsis
- McMaster receives new Canadian Cancer Society grants for groundbreaking research
- Tecnologie Avanzate, Naviscan sign deal to distribute PET scanner in Italy
- Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma
- FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patie
- FDA clears Sectra's digital mammography system
- ChipDX identifies gene expression signature in early-stage breast tumors
- Breast shields can protect women from radiation exposure during CT exams
- Researchers identify regulatory protein that can inhibit cancer metastasis
- Researchers discover new mechanism by which BRCA1 gene mutations can induce breast ca
- New poll: 57% of women believe mammograms should start at age 40
- Researchers identify unexpected triple-negative breast cancer marker
- Two breast cancer genomic tests produce broadly similar results for high and low-risk
- Insight into breast cancer
- Genome epigenetic analysis reveals new ways to detect and treat breast cancer
- Clinical study: Celecoxib drug may treat breast cancer
- ZIOPHARM reports net loss of $39.0 million for first quarter 2011
- CytRx reports $6.3 million net loss for first quarter 2011
- CanTeen launches groundbreaking cancer support system
- Mammogram appointments delayed by up to 148 days: NYC report
- CAMH presents new Microvolt T-wave Alternans testing data at Heart Rhythm Society mee
- UT Southwestern researcher identifies estrogen's effect on breast cancer cells
- AGA honors four young gastroenterologists with prestigious Research Scholar Awards
- First Edition: May 6, 2011
- All California women can find affordable preventive care options
- Study confirms prognostic role of CTC in metastatic breast cancer
- New stem cell finding opens door for novel triple negative breast cancer therapies
- Study analyzes breast-feeding frequency of infants in eight inner-city Philadelphia h
- Breast cancer linked to lifestyle & three new genes
- Mary Ann Liebert publishes new journal on cancer care for adolescent and young adult
- GTx reports net loss of $2.6 million for first quarter 2011
- Acceleron presents RAP-661 preclinical data in osteopenic mice at International meeti
- Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in
- Rapid blood-based test can determine patients with SLE
- Seven-time Tour de France champion to raise funds for CBCF's cancer research initiati
- Coffee consumption can reduce risk of ER-negative breast cancer in women
- Breast cancer and unhealthy lifestyle choices
- Genetic test to identify women at higher risk of breast cancer could reduce risks ass
- Women with invasive breast cancer can benefit from new genomic test
- ImmunID, Cytheris commence CYT107 and XELODA Phase IIa trial in metastatic breast can
- INESC Porto, FC and FMUP to hold international seminar on breast cancer
- Researchers look for surrogate endpoints to predict early benefit of cancer drugs
- INESC Porto, FEUP develop software to automatically analyse and validate mammograms
- Major upgrades to somo•v Automated Breast Ultrasound System to be showcased at SBI Me
- Biocept's paper describes identification of different CTC phenotypes in cancer patien
- Coffee provides protections from a type of breast cancer: Study
- ACR to honor UCLA cancer researcher with Gold Medal for radiology work
- ACS, PGi celebrate 10 years of partnership on key cancer initiatives
- Rethink praises Ontario's decision to provide breast cancer patients with Herceptin
- ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer
- New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20
- NewGene develops breakthrough test for hereditary breast cancer
- International researchers discover new aspect of 'metabolic transformation'
- PGT, Quintiles collaborate to bring genomic testing into mainstream drug development
- New biomarker can predict breast cancer recurrence
- Cytori Therapeutics announces independent clinical study results in breast reconstruc
- New avenue for treating breast cancer
- Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prosta
- CITN selects Cytheris' CYT107 for initial clinical trials at network institutions
- Clinical PET system for early stage breast cancer diagnosis
- U-Systems introduces RCC Transducer Technology for somo•v Automated Breast Ultrasound
- Estradiol may exacerbate tumor growth in breast cancer
- Yoga offers unique benefits beyond fighting fatigue for women with breast cancer
- Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancer at ASCO annua
- New breast cancer biomarker may help identify women's response to tamoxifen
- APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage
- On Op-Ed pages, controversies abound: Romney, Gingrich, abortion, telemedicine, cance
- Silence to present new Atu027 Phase I study data in advanced solid tumors at ASCO ann
- AstraZeneca announces encouraging results from olaparib phase II study in serous ovar
- Simple home-based colon cancer screening test can prevent many unnecessary deaths in
- RXi to present updated NeuVax Phase II trial data in breast cancer at ASCO 2011
- Mitomics enters licensing agreement with QDx Pathology Services for QPredict Prostate
- Enzon to discontinue PEG-SN38 clinical program in metastatic colorectal cancer
- Bayer, Onyx to present Nexavar-chemotherapy combination Phase 2b trial data in breast
- EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA
- Bristol-Myers Squibb to present abstracts on oncology compounds at ASCO 2011 Annual M
- Breast cancer survivors, advocates stress importance of Every Woman Counts program
- FDA approves SUTENT for treatment of pancreatic NET
- Researchers identify new drug resistant protein in breast cancer
- Scientists find new drug target in breast cancer
- Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results i
- Variant of obesity gene may increase breast cancer risk
- Researchers discover protein switch that can trigger heart failure
- Patient accrual complete in Provectus PH-10 Phase 2C clinical trial for treatment of
- Most Cancer Patients Like Full Access to Records
- Positive preliminary results from Genomic Health's Oncotype DX study in DCIS breast c
- Lipofilling seems to be safe procedure for breast cancer patients, study suggests
- Neoprobe, Devicor sign gamma detection device asset purchase agreement
- Low vitamin D could account for link between obesity and cancer, heart disease, diabe
- Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASC
- Tigris Pharmaceuticals begins enrollment in AFP-464 Phase 2 trial in ER-positive brea
- Folic acid during pregnancy reduces rate of colon cancer in offspring
- Tacrolimus prevents breast cancer growth in pre-clinical studies
- Lactate shuttle also exists in human tumors
- Nutribar, CBCF partner to support breast cancer research
- New insights into pathogenesis and treatment of hereditary breast, ovarian cancer
- Novartis employees to do volunteer work for non-profit groups during 15th annual Comm
- Canadian women more aware of ovarian cancer now, but misconceptions remain
- Two Almac's main research projects on ovarian, breast cancer to be presented at ASCO
- Enrollment complete in BioSante's LibiGel Phase III cardiovascular and breast cancer
- Latest Breast cancer screening guidelines deemed unsafe by 80% women
- Type II diabetes drug may slow or stop breast cancer tumor metastasis
- IPSOGEN announces two studies on Genomic Grade test to be presented at ASCO 2011
- Breast fat transfer procedure can achieve twofold increase in breast size
- Researchers discover overactive genes that drive triple-negative breast cancer cells
- Data from final analysis of AVEO's tivozanib Phase 2 trial in kidney cancer presented
- Elevated CRP levels predict poor prognosis of breast cancer
- Syndax receives U.S. patent for entinostat to treat metastatic cancers
- Many women over 70 with stage I breast cancer opt for radiation therapy: ASCO
- Telethermographic device is not approved for screening breast cancer
- Nuvera announces results of blinded study on breast cancer assay for taxane chemother
- Princess Margaret Hospital Foundation, Canadian Cancer Society to raise funds towards
- PTEN does not reduce effectiveness of breast cancer drug, Herceptin: Study
- Thermography should not be used instead of mammography for breast cancer screening, F
- Additional data supporting utility of PAM50 gene signature for breast cancer to be pr
- Researcher to evaluate new approach for treatment of triple-negative breast cancer
- Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2
- HRT reduces risk of breast cancer in women with BRCA mutations after ovary removal
- Starving breast cancer cells of hedgehog significantly slows tumour growth and spread
- Bionovo's Menerba Phase 2 trial data to be presented at Annual World Congress on Meno
- U of A researchers try to combat heart disease in cancer patients
- Exemestane reduces risk of breast cancer in high-risk, postmenopausal women
- Alnylam's ALN-VSP Phase I trial data on liver cancer presented at ASCO 2011
- Ipsen decides to assess development of Irosustat in combination with hormonal therapi
- Women with breast cancer do not benefit from flaxseed
- Anti-Mullerian hormone test can indicate reproductive function in young women with ca
- Additional radiation treatment holds promise for breast cancer surgery patients
- Study suggests strong link between dying from breast cancer and being obese
- NCIC CTG's exemestane clinical trial data on breast cancer presented at ASCO 2011
- GTx to initiate two Ostarine Phase III trial for treatment of muscle wasting in patie
- AstraZeneca receives AmeriCares' Power of Partnership Award for global health program
- Positive results from RXi NeuVax Phase 2 trial on breast cancer presented at ASCO 201
- Teva's lipegfilgrastim-pegfilgrastim comparative Phase III study in breast cancer mee
- Manhattan acquires Senior Scientific
- APP to commence marketing Letrozole Tablets for breast cancer in the U.S.
- Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011
- Scientists discover key molecule that targets tumour blood vessels
- Increases in VEGF-family markers in metastatic colorectal cancer patients associated
- Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breas
- FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold
- Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 st
- Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced
- ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO
- Mother's blueberry consumption can improve mammary gland health in offspring
- NYU Cancer Institute scientists present new research findings at ASCO 2011
- Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer present
- Health-care professionals, researchers to attend Sixth World Conference on Breast Can
- U.S. cancer drugs shortage has doctors scrambling
- Researchers identify key molecule responsible for breast tumor metastasis
- New NCIN report: Poorer women more likely to die from breast cancer
- Neoprobe's Lymphoseek Phase 3 trial data presented at SNM annual meeting
- Scientists uncover new role for key cancer protein
- Sulforaphane-rich foods safe and effective for preventing cancer
- FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma
- Spanish scale measures concern about cancer in healthy people
- Surgeon uses radiotracer to detect the ganglion through which tumour attempts to spre
- LA/hypnosis combination during surgery can aid healing process, reduce drug use and h
- McMaster researchers: Routine autism screening not needed for children
- Roundup: States controlled by GOP pass sweeping changes; state budgets still very lea
- Ventana Medical receives FDA approval for new breast cancer genetic test
- Change in diet can reduce cancer risk
- Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer
- QIAGEN to acquire Ipsogen
- Statistics of breast cancer risk
- Childhood cancer survivors at increased risk of new cancers in middle age
- Magnesium essential for absorption and metabolism of vitamin D and calcium
- Sheep diagnoses breast cancer
- Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conf
- State roundup: Mass. health spending's rise; huge Ky. hospital merger
- Train the brain to manage chronic pain
- Older women in the UK less likely to have surgery for breast cancer than younger ones
- Study shows deprivation leads to cancer inequality in England
- Food-based soy products safe for breast cancer survivors, expert says
- Scientists create first roadmap to understand estrogen signaling in breast cancer cel
- Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hea
- Cancer Statistics 2011 report finds not all segments of the population have benefitte
- Two thirds of women with breast cancer more likely to die from cardiovascular disease
- Novel biomarker-development pipeline approach for human diseases
- Panacea Global announces name change
- Genetic Technologies introduces BREVAGen genetic test for assessing non-familial brea
- California-born Asian and Pacific Islander women face higher risks of breast cancer
- Nine young clinical investigators earn recognition from Damon Runyon Cancer Research
- ImmunoCellular Therapeutics at World Cancer Vaccines Summit (6/23/11, Boston)
- BHGI, Shanghai CDC to form Breast Health Resource Center in China
- Proton beam radiotherapy appears to control breast cancer with minimal side-effects
- Silicone gel-filled breast implants: FDA releases updated data
- CHW interventions linked to increased rates of mammography screening
- Unavailability of Avastin more dangerous risk for breast cancer patients, says FAMEDS
- New model estimates impact of lifestyle changes on absolute breast cancer risk
- Philips to acquire Sectra's mammography modality operations
- Many women with advanced breast cancer do not receive radiation after mastectomy
- Study aims to find out whether blood screening can diagnose early breast cancer
- First Edition: June 27, 2011
- Androgen receptors trigger cancer cell growth in oestrogen-receptor-negative breast c
- Researchers demonstrate how Runx3 protein could suppress breast cancer tumor growth
- Mammography screening prevents breast cancer deaths in women
- FDA hearing on breast cancer drug set for this week
- Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer
- Women can benefit from immediate breast reconstruction following mastectomy
- Researchers, policy experts to examine issue of declining enrollment in clinical tria
- Breast cancer patients not getting recommended radiation therapy: Report
- Many advanced breast cancer patients do not receive postmastectomy radiation therapy
- First Edition: June 28, 2011
- Screening with mammography reduces deaths from breast cancer
- Conventional Estrogen Receptor measurement methods may result in 10-20% false negativ
- New prostate cancer drugs bring cost of care into spotlight
- PEP intervention increases breast cancer awareness
- Patients, scientists in different corners for cancer drug fight
- FDA looks at Avastin risks
- Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate
- FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer
- Provectus presents additional data on PV-10 at two separate melanoma conferences
- TCGA examines ovarian serous adenocarcinoma tumors from 500 patients
- New technology reduces stress of scheduling chemotherapy treatments
- First Edition: June 30, 2011
- Positive results from Nexavar Phase 2b trial on breast cancer presented at ASCO
- Panel advises FDA to reject Avastin as breast cancer drug
- Avastin for breast cancer still covered by Medicare despite FDA indecision
- Scientists discover enzyme that can regulate breast cancer development
- Two defective genes may cause telomere elongations in cancer cells: Study
- Six new scientists to receive SWCRF grants for cancer research
- First Edition: July 1, 2011
- Medicare to cover 2 expensive cancer drugs
- Medical practitioners can help reduce breast cancer deaths in African-American women
vBulletin® v3.8.7, Copyright ©2000-2024, vBulletin Solutions, Inc.